Tedavi Lifesciences Private Limited
Pharmaceutical company that manufactures, markets, and exports drugs, essential oils, and herbal extracts.
2016 | Delhi (India) | Active
Tedavi Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.25 Cr
- Revenue Growth -91.43%
- Profit Growth -187.99%
- Ebitda -111.43%
- Net Worth -71.01%
- Total Assets -80.89%
About Tedavi Lifesciences
Tedavi Lifesciences Private Limited (TLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 July 2016 (Eight years and eight months 26 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.25 Cr.
Manoj Gupta and Chander Gupta serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U51909DL2016PTC303129
- Company No.
303129
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
Tedavi Lifesciences Private Limited
Explore comprehensive data for Tedavi Lifesciences Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Tedavi Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Gupta  | Director | 18-Jul-2016 | Current |
| Chander Gupta | Director | 18-Jul-2016 | Current |
Financial Performance of Tedavi Lifesciences.
Tedavi Lifesciences Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 91.43% decrease. The company also saw a substantial fall in profitability, with a 187.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 71.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tedavi Lifesciences?
In 2024, Tedavi Lifesciences had a public holding of 51.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cmg Biotech Private LimitedManoj Gupta is a mutual person
Charges (Loans)
Open Charges
₹22.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 2.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 2021 | Others | ₹2.25 Cr | Open |
How Many Employees Work at Tedavi Lifesciences?
Unlock and access historical data on people associated with Tedavi Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tedavi Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tedavi Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Tedavi Lifesciences
Recent activity within the organization
- Annual General Meeting
Tedavi Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Tedavi Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Others amounted to Rs. 22.50 M with Charge ID 100499268 was registered on 09 Apr 2021.
- Director Appointment
Manoj Kumar Gupta was appointed as a Director was appointed as a Director on 18 Jul 2016 & has been associated with this company since 8 years 8 months .
- Director Appointment
Chander Kala Gupta was appointed as a Director was appointed as a Director on 18 Jul 2016 & has been associated with this company since 8 years 8 months .
- Company Incorporation
Tedavi Lifesciences Private Limited was registered on 18 Jul 2016 with Roc Delhi & aged 8 years 8 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Tedavi Lifesciences Private Limited?
Tedavi Lifesciences Private Limited was incorporated on 18 Jul 2016.
What is authorized share capital and paid-up capital of Tedavi Lifesciences Private Limited?
The authorized share capital of Tedavi Lifesciences Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Tedavi Lifesciences Private Limited?
Currently 2 directors are associated with Tedavi Lifesciences Private Limited.
- Manoj Kumar Gupta
- Chander Kala Gupta
What is the registered address of Tedavi Lifesciences Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Tedavi Lifesciences Private Limited is A-102, Ground Floor Madhuban India, Delhi, 110092.
What is the corporate identification number (CIN) and company number of Tedavi Lifesciences Private Limited?
The corporate identification number (CIN) of Tedavi Lifesciences Private Limited is U51909DL2016PTC303129 and the company number is 303129 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Tedavi Lifesciences Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Tedavi Lifesciences Private Limited has fallen by -91.43%.
What change has been observed in the net worth of Tedavi Lifesciences Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Tedavi Lifesciences Private Limited has experienced an downturn of -71.01%.
What are the total open charges for Tedavi Lifesciences Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Tedavi Lifesciences Private Limited amount to ₹ 2.25 Cr.
When was the last Balance Sheet of Tedavi Lifesciences Private Limited filed with the ROC?
The most recent Balance Sheet for Tedavi Lifesciences Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records